Galit Alter

Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine.

Nielsen CM, Barrett JR, Davis C, Fallon JK, Goh C, Michell AR, Griffin C, Kwok A, Loos C, Darko S, Laboune F, Tekman M, Diouf A, Miura K, Francica JR, Ransier A, Long CA, Silk SE, Payne RO, Minassian AM, Lauffenburger DA, Seder RA, Douek DC, Alter G, Draper SJ.

JCI Insight. 2023 Jan 24. 8(2). PMID: 36692019

Humoral signatures of MOG-antibody-associated disease track with age and disease activity.

Spatola M, Chuquisana O, Jung W, Lopez JA, Wendel EM, Ramanathan S, Keller CW, Hahn T, Meinl E, Reindl M, Dale RC, Wiendl H, Lauffenburger DA, Rostásy K, Brilot F, Alter G, Lünemann JD.

Cell Rep Med. 2023 Jan 10. 100913. PMID: 36669487

Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine Myocarditis.

Yonker LM, Swank Z, Bartsch YC, Burns MD, Kane A, Boribong BP, Davis JP, Loiselle M, Novak T, Senussi Y, Cheng CA, Burgess E, Edlow AG, Chou J, Dionne A, Balaguru D, Lahoud-Rahme M, Arditi M, Julg B, Randolph AG, Alter G, Fasano A, Walt DR.

Circulation. 2023 Jan 04. PMID: 36597886

Author Correction: The persistence of memory: defining, engineering, and measuring vaccine durability.

Palin AC, Alter G, Crotty S, Ellebedy AH, Lane MC, Lee FE, Locci M, Malaspina A, Mallia C, McElrath MJ, Pulendran B, Singh A, D'Souza MP.

Nat Immunol. 2023 Jan. 24(1):200. PMID: 36572838

Antibody effector functions are associated with protection from respiratory syncytial virus.

Bartsch YC, Cizmeci D, Kang J, Zohar T, Periasamy S, Mehta N, Tolboom J, Van der Fits L, Sadoff J, Comeaux C, Callendret B, Bukreyev A, Lauffenburger DA, Bastian AR, Alter G.

Cell. 2022 12 22. 185(26):4873-4886.e10. PMID: 36513064

BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children.

Bartsch YC, Chen JW, Kang J, Burns MD, St Denis KJ, Sheehan ML, Davis JP, Edlow AG, Balazs AB, Yonker LM, Alter G.

NPJ Vaccines. 2022 Dec 03. 7(1):158. PMID: 36463314

The persistence of memory: defining, engineering, and measuring vaccine durability.

Palin AC, Alter G, Crotty S, Ellebedy AH, Lane MC, Lee FE, Locci M, Malaspina A, Mallia C, McElrath MJ, Pulendran B, Singh A, D'Souza MP.

Nat Immunol. 2022 12. 23(12):1665-1668. PMID: 36456737

Fc mediated pan-sarbecovirus protection after alphavirus vector vaccination.

Adams LE, Leist SR, Dinnon KH, West A, Gully KL, Anderson EJ, Loome JF, Madden EA, Powers JM, Schäfer A, Sarkar S, Castillo IN, Maron JS, McNamara RP, Bertera HL, Zweigert MR, Higgins JS, Hampton BK, Premkumar L, Alter G, Montgomery SA, Baxter VK, Heise MT, Baric RS.

bioRxiv. 2022 Nov 28. PMID: 36482964

Fc? receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2.

Mackin SR, Desai P, Whitener BM, Karl CE, Liu M, Baric RS, Edwards DK, Chicz TM, McNamara RP, Alter G, Diamond MS.

bioRxiv. 2022 Nov 28. PMID: 36482975

SARS-CoV-2 mRNA vaccination elicits robust antibody responses in children.

Bartsch YC, St Denis KJ, Kaplonek P, Kang J, Lam EC, Burns MD, Farkas EJ, Davis JP, Boribong BP, Edlow AG, Fasano A, Shreffler WG, Zavadska D, Johnson M, Goldblatt D, Balazs AB, Yonker LM, Alter G.

Sci Transl Med. 2022 11 23. 14(672):eabn9237. PMID: 35881018